Form 4: CME Group CEO Duffy Sells Shares for Tax Obligations
Insider Transaction Report
CME Group Chairman and CEO Terrence A. Duffy disposed of 10,210 shares of Common Stock Class A on December 31, 2025, to cover tax withholding obligations related to restricted stock vesting.
Summary
- Terrence A. Duffy, Chairman and CEO of CME Group Inc. [CME], reported a transaction on December 31, 2025.
- Duffy disposed of 10,210 shares of CME Group Class A Common Stock at a price of $273.08 per share.
- The transaction was executed to satisfy tax withholding obligations associated with the vesting of restricted stock.
- Following this transaction, Duffy directly beneficially owns 55,594 shares of CME Group Common Stock Class A.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.
Sentiment
Score: 5
Explanation: The transaction is a routine, non-discretionary sale for tax withholding purposes, which is neutral in terms of sentiment regarding the company's performance or outlook.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Management Comments
- Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/2025.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction, specifically a non-discretionary sale to cover tax liabilities upon the vesting of equity awards. Such transactions are common for executives receiving restricted stock units as part of their compensation and are generally not indicative of management's sentiment towards the company's future prospects.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Disclosure | The transaction was made pursuant to a Rule 10b5-1(c) plan, which is a pre-arranged trading plan designed to allow insiders to buy or sell company stock without concerns about insider trading, provided the plan is established in good faith and at a time when the insider is not in possession of material non-public information. | 12/31/2025 | This indicates adherence to best practices in corporate governance regarding insider trading, providing transparency and mitigating potential conflicts of interest. |
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and does not reflect a change in management's confidence or company fundamentals.
- Employees: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | Date of transaction where shares were disposed of for tax withholding. |
| 01/02/2026 | Date the Form 4 was filed. |
Recommendation
holdThis Form 4 filing details a routine, non-discretionary sale of shares by CME Group's Chairman and CEO, Terrence A. Duffy, to cover tax withholding obligations upon the vesting of restricted stock. Such transactions are common for executives and are typically pre-arranged under a Rule 10b5-1 plan, indicating they are not based on new material information. Therefore, this specific transaction does not provide new insights into the company's financial health or strategic direction that would warrant a change in investment recommendation. The stock's performance should continue to be evaluated based on CME Group's operational results, market conditions, and broader industry trends.
Keywords
CME Group, Terrence Duffy, Form 4, insider transaction, stock sale, tax withholding, restricted stock, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.